The Canadian Diabetes Association Announces Elsevier as New Publisher of the Canadian Journal of Diabetes Starting in 2012
Toronto, November 17, 2011 - The Canadian Diabetes Association is pleased to announce that it has entered into an agreement with Elsevier to publish the Canadian Journal of Diabetes (CJD) beginning in January 2012.
CJD is Canada’s only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes healthcare professionals and scientists. It promotes the sharing and enhancement of knowledge to advance the prevention, cure and management of diabetes and related diseases. The journal publishes original research articles and expert reviews, ranging from basic sciences to clinical applications, education, public and population health, and health policy.
“We are very pleased to be partnering with Elsevier,” said Michael Cloutier, President and CEO, Canadian Diabetes Association. “They are an innovative and leading publisher in medical information and, together, we will bring the Canadian Journal of Diabetes to new heights of excellence.”
Andrew Miller, Executive Publisher, Global Medical Research, Elsevier stated, “We are very proud to be chosen as publisher forCanadian Journal of Diabetes.We look forward to further developing CJD in partnership with the Canadian Diabetes Association for the diabetes research and clinical-care communities.”
Under the agreement with Elsevier, the Association will still own the journal, maintain copyright, and retain full editorial control. Elsevier will manage CJD publication, website features, print and online subscriptions, advertising, and marketing.
The decision to partner with Elsevier was reached by the Association after a long and thorough review process. The advantages of Elsevier’s global reach and experience in the ever-changing field of scientific publication will not only benefit the CJD and its authors, but its readers as well.
# # #
About the Canadian Diabetes Association
Across the country, the Canadian Diabetes Association is leading the fight against diabetes by helping people with diabetes live healthy lives while we work to find a cure. Our community-based network of supporters help us provide education and services to people living with diabetes, advocate for our cause, break ground towards a cure and translate research into practical applications. Visit www.diabetes.ca; www.facebook.com/CanadianDiabetesAssociation; on Twitter @DiabetesAssoc; call +1-800-BANTING (226 8464).
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com